Company intelligence / Profile preview

Dermozone

Anakapalle, Visakhapatnam, Andhra Pradesh, Indiasecondmedic.com ↗

Ownership: Private
Development stage: Commercial

Overview

Dermozone has developed multiple commercial products including dalethyne, a revolutionary chemical molecule compound proven as an antimicrobial agent for wound healing[4]. They also offer various skincare and pharmaceutical products that have shown effectiveness in treating various skin conditions[1][3].

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Topical formulationsOral applications
Industry: Biotech

Drug pipeline

1 asset

MedCare Ozonated olive oil

Commercial

Indications: Acne, Fungal infections, Dry skin, Insect bites, Athlete's foot, Eczema, Diabetic wounds, Burns

Beyond the preview

Go deeper on Dermozone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermozone.

Explore the full profile